Announcements - OBI Pharma 台灣浩鼎

2018.May.16

Amendment on the announcement for 2018 Annual General Meeting (discussion notes)

2018.May.11

The board of directors of the company resolved to request the shareholders to authorize the board of directors to handle cash-increase of common shares to issue overseas depository receipts

2018.May.11

The board of directors of the company resolved to request the shareholders to authorize the board of directors to handle private placement of common shares at the Annual General Meeting

2018.May.11

Amendment on the announcement for 2018 Annual General Meeting

2018.May.11

Announcement of change of accountant due to internal adjustment of the accounting firm

2018.Apr.20

Announcement based on the procedures for acquisition or disposal of assets

2018.Apr.19

FDA Clearance of OBI-3424 IND Application for A Phase I/II Study Targeting AKR1C3 Solid Tumors

2018.Mar.19

OBI Pharma Inc. to attend Credit Suisse Asian Investment Conference

2018.Mar.09

Announcement on the Change of Chief Financial Officer

2018.Mar.09

OBI Pharma’s Board of Directors approves the announcement of the Company’s 2017 individual and consolidated financial statements

News

Latest News

Events

Latest events